Angiogenic and neurotrophic effects of vascular endothelial growth factor (VEGF165): Studies of grafted and cultured embryonic ventral mesencephalic cells

Experimental Neurology

Volumn 182, Issue 2, 2003, Pages 435-445

  Pitzer, Mark R ^a   Sortwell, Caryl E ^a   Daley, Brian F ^a   McGuire, Susan O ^a   Marchionini, Deanna ^a   Fleming, Matthew ^a   Collier, Timothy J ^a,b  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b Department of Neurological Sciences ^*  (United States)

Author keywords

Angiogenesis; Hypoxia; Ischemia; Mesencephalon; Parkinson's disease; Striatum; Substantia Nigra; Transplant

Indexed keywords

AMPHETAMINE; DOPAMINE; OXIDOPAMINE; SODIUM CHLORIDE; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN 165;

ALLOGRAFT; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BOLUS INJECTION; BRAIN BLOOD VESSEL; BRAIN CAPILLARY; BRAIN INJURY; CELL CULTURE; CELL SURVIVAL; CELL TRANSPLANTATION; CONTROLLED STUDY; DISEASE MODEL; DOPAMINERGIC NERVE CELL; DRUG EFFECT; DRUG SCREENING; EMBRYO; EMBRYO CELL; EXPERIMENT; GLIA; GRAFT SURVIVAL; IMMUNOREACTIVITY; IN VIVO STUDY; INJECTION SITE; MALE; MEASUREMENT; MESENCEPHALON; NERVE CELL GROWTH; NERVE FIBER GROWTH; NEURITE; NEUROTROPISM; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; STRIATE CORTEX; VASODILATATION;

EID: 0042665632     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-4886(03)00100-6     Document Type: Article

References (54)

1. Barker R.A., Dunnett S.B., Faissner A., Fawcett J.W. The time course of loss of dopaminergic neurons and the gliotic reaction surrounding grafts of embryonic mesencephalon to the striatum. Exp. Neurol. 141:1996;79-93.
2. Banai S., Jaklitsch M.T., Shou M., Lazarous D.F., Scheinowitz M., Biro S., Epstein S.E., Unger E.F. Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. Circulation. 89:1994;2183-2183.
3. Björklund A., Lindvall O. Cell replacement therapies for central nervous system disorders. Nature Neurosci. 3:2000;537-544.
4. Björklund A., Stenevi U. Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants. Brain Res. 177:1979;555-560.
5. Breier G., Albrecht U., Sterrer S., Risau W. Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. Development. 114:1992;521-532.
6. Brewer G.J., Torricelli J., Evege E.K., Price P.J. Optimized survival of hippocampal neurons in B27-supplemented neurobasal, a new serum-free medium combination. J. Neurosci Res. 35:1993;567-578.
7. Broadwell R.D., Charlton H.M., Balin B.J., Salcman M. Angioarchitecture of the CNS, pituitary gland, and intracerebral grafts revealed with peroxidase cytochemistry. J. Comp. Neurol. 260:1987;47-62.
8. Broadwell R.D., Chalton H.M., Ebert P.S., Hickey W.F., Shirazi Y., Villegas J., Wolf A.L. Allografts of CNS tissue possess a blood-brain barrier. II. Angiogenesis in solid tissue and cell suspension graft. Exp. Neurol. 112:1991;1-28.
9. Brundin P., Björklund A. Survival, growth and function of dopamine neurons grafted to the brain. Prog. Brain Res. 71:1987;293-308.
10. Brundin P., Björklund A. Survival, of expanded dopaminergic precursors is critical for clinical trials. Nature Neurosci. 1:1987;537.
11. Chleboun J.O., Martins R.N., Mitchell C.A., Chirila T.V. bFGF enhances the development of the collateral circulation after acute arterial occlusion. Biochem. Biophys. Res. Commun. 185:1992;510-516.
12. Connolly D.T. Vascular permeability factor a unique regulator of blood vessel function . J. Cell Biochem. 47:1991;219-223.
13. Collier T.J., Sortwell C.E., Daley B.F. Diminished viability, growth, and behavioral efficacy of fetal dopamine neuron grafts in aging rats with long-term dopamine depletion an argument for neurotrophic supplementation . J. Neurosci. 19:1999;5563-5573.
14. Dusart I., Nothias F., Roudier F., Besson J.M., Peschanski M. Vascularization of fetal cell suspension grafts in the excitotoxically lesioned adult rat thalamus. Dev. Brain Res. 48:1989;215-228.
15. Dvorak H.F., Brown L.F., Detmar M., Dvorak A.M. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability and angiogenesis. Am. J. Pathol. 146:1995;1029-1039.
16. Ferrara N., Henzel W.J. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem. Biophys. Res. Commun. 161:1989;851-858.
17. Ferrara N., Houch K., Jakeman L., Leung D. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr. Rev. 13:1992;18-32.
18. Fletcher S. Innovative treatment or ethical headache? Fetal transplantation in Parkinson's disease. Prof. Nurse. 7:1992;592.
19. Freeman T.B., Olanow C.W., Hauser R.A., Nauert G.M., Smith D.A., Borlongan C.V., Sanberg P.R., Holt D.A., Kordower J.H., Vingerhoet A.B. Bilateral fetal nigral transplantation into the post commisural putamen in Parkinson's disease. Ann. Neurol. 38:1995;379-388.
20. Kitsukawa T., Shimizu M., Sanbo M., Hirata T., Taniguchi M., Bekku Y., Yagi T., Fujisawa H. Neuropilin-semaphorin III/D mediated chemorepulsive signals play a crucial role in peripheral nerve projections in mice . Neuron. 19:1997;995-1005.
21. Kordower J.H., Rosenstein J.M., Collier T.J., Burke M.A., Chen E.Y., Li J.M., Martel L., Levey A.E., Mufson E.J., Freeman T.B., Olanow C.W. Functional fetal nigral grafts in a patient with Parkinson's disease chemoanatomic, ultrastructural, and metabolic studies . J. Comp. Neurol. 370:1996;203-230.
22. Krum J.M., Mani N., Rosenstein J.M. Angiogenic and astroglial responses to vascular endothelial growth factor administration in adult rat brain. Neuroscience. 110:2002;589-604.
23. Krum J.M., Rosenstein J.M. Patterns of angiogenesis in neural transplant models. II. Fetal neocortical transplants. J. Comp. Neurol. 271:1988;331-345.
24. Krum J.M., Rosenstein J.M. VEGF mRNA and its receptor flt-1 are expressed in reactive astrocytes following neural grafting and tumor cell implantation in the adult CNS. Exp. Neurol. 154:1998;57-65.
25. Krum J.M., Rosenstein J.M. Transient coexpression of nestin, GFAP, and vascular endothelial growth factor in mature reactive astroglia following neural grafting or brain wounds. Exp. Neurol. 160:1999;348-360.
26. Lopez J.J., Laham R.J., Stamler A., Pearlman J.D., Bunting S., Kaplan A., Carrozza J.P., Sellke F.W., Simons M. VEGF administration in chronic myocardial ischemia in pigs. Cardiovasc. Res. 40:1998;272-281.
27. Mahalik T.J., Hahn W.E., Clayton G.H., Owens G.P. Programmed cell death in developing grafts of fetal substantia nigra. Exp. Neurol. 129:1994;27-36.
28. Nikkhah G., Cunningham M.G., Jödicke A., Knappe U., Björklund A. Improved graft survival and striatal reinnervation by microtransplantation of fetal nigral cell suspensions in the rat Parkinson model. Brain Res. 633:1994;133-143.
29. Olanow C.W., Kordower J.H., Freeman T.B. Fetal nigral transplantation as a therapy for Parkinson's disease. Trends Neurosci. 19:1996;102-109.
30. Olson L., Seiger A., Stromberg I. Intraocular transplantation in rodents a detailed account of the procedure and example of its use in neurobiology with special reference to brain tissue grafting . Federoff S. Advances in Cellular Neurobiology. Vol. 4:1982;Academic Press, New York.
31. Papavassiliou E., Gogate N., Proescholdt M., Heiss J.D., Walbridge S., Edwards N.A., Oldfield E.H., Merrill M.J. Vascular endothelial growth factor (vascular permeability factor) expression in injured rat brain. J. Neurosci. Res. 49:1997;451-460.
32. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 1998;Academic Press, New York.
33. Piccini P., Brooks D.J., Bjorklind A., Gunn R.N., Grasby P.M., Rimoldi O., Brundin P., Hagell P., Rehncrona S., Widner H., Lindvall O. Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient. Nature Neurosci. 2:1999;1137-1140.
34. Pearce W.J. Mechanisms of hypoxic cerebral vasodilatation. Pharmacol. Ther. 65:1995;75-91.
35. Plouet J., Schilling J., Gospodarowicz D. Isolation and characterization of a newly identified endothelial cell mitogen produced by AtT-20 cells. EMBO J. 8:1989;3801-3806.
36. Proescholdt M.A., Heiss J.D., Walbridge S., Muhlhauser J., Capogrossi M.C., Oldfield E.H., Merrill M.J. Vascular endothelial growth factor (VEGF) modulates vascular permeability and inflammation in rat brain. J. Neuropathol. Exp. Neurol. 58:1999;613-627.
37. Risau W. Mechanisms of angiogenesis. Nature. 386:1997;671-674.
38. Robertson P.L., Du Bois M., Bowman P.D., Goldstein G.W. Angiogenesis in developing rat brain an in vivo and in vitro study . Brain Res. 355:1985;219-223.
39. Romanul F.C.A., Bannister R.G. Localized areas of high alkaline phosphatase activity in the terminal arterial tree. J. Cell Biol. 15:1962;73-84.
40. Rosenstein J.M., Mani N., Silverman W.F., Krum J.M. Patterns of brain angiogenesis after vascular endothelial growth factor administration in vitro and in vivo. Proc. Natl. Acad. Sci. USA. 95:1998;7086-7091.
41. Rosenstein J.M., Brightman M.W. Intact cerebral ventricle as a site for tissue transplantation. Nature. 275:1978;83-85.
42. Schmidt R.H., Bjorklund A., Stenevi U., Dunnett S.B., Gage F.H. Intracerebral grafting of neuronal cell suspensions. III. Activity of intrastriatal nigral suspension implants as assessed by measurements of dopamine synthesis and metabolism. Acta Physiol. Scand. 522:(Suppl):1983;19-28.
43. Senger D.R., Galli S.J., Dvorak A.M., Peruzzi C.A., Harvey V.S., Dvorak H.F. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science. 219:1983;983-985.
44. Silverman W.F., Krum J.M., Mani N., Rosenstein J.M. Vascular, glial and neuronal effects of vascular endothelial growth factor in mesencephalic explant cultures. Neuroscience. 90:1999;1529-1541.
45. Sondell M., Lundborg G., Kanje M. Vascular endothelial growth factor has neurotrophic activity and stimulates axonal outgrowth, enhancing cell survival and Schwann cell proliferation in the peripheral nervous system. J. Neurosci. 19:1999;5731-5740.
46. Sortwell C.E., Camargo M.D., Pitzer M.R., Gyawali S., Collier T.J. Diminished survival of mesencephalic dopamine neurons grafted into aged hosts occurs during the immediate postgrafting interval. Exp. Neurol. 169:2001;23-29.
47. Sortwell C.E., Pitzer M.R., Collier T.J. Time course of apoptotic cell death within mesencephalic cell suspension grafts implications for improving grafted dopamine neuron survival . Exp. Neurol. 165:2000;268-277.
48. Stenevi U., Björklund A., Svendgaard N.-A. Transplantation of central and peripheral monoamine neurons to the adult rat brain techniques and conditions for survival . Brain Res. 114:1976;1-20.
49. Svendsen C.N., Smith A.G. New prospects for human stem-cell therapy in the nervous system. Trends Neurosci. 22:1999;357-364.
50. Takeshima T., Shimoda K., Johnston J.M., Commissiong J.W. Standardized methods to bioassay neurotrophic factors for dopaminergic neurons. J. Neurosci. Methods. 67:1996;27-41.
51. + channels mediate dilatation of cerebral arterioles during hypoxia. Circ Res. 74:1994;1005-1008.
52. Widner H., Tetrud J., Rehncrona S., Brundin P., Gustavi B., Bjorklund A., Lindvall O., Langston J.W. Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). N. Engl. J. Med. 327:1992;1556-1563.
53. Yancopoulos G.D., Davis S., Gale N.W., Rudge J.S., Wiegand S.J., Houlash J. Vascular-specific growth factors and blood vessel formation. Nature. 407:2000;242-248.
54. Zawada W.M., Zastrow D.J., Clarkson E.D., Adams F.S., Bell K.P., Freed C.R. Growth factors improve immediate survival of embryonic dopamine neurons after transplantation into rats. Brain Res. 786:1998;96-103.